Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
Copart (CPRT): Weighing the Path to the $39 Target and a +26% Gain

Copart (CPRT): Weighing the Path to the $39 Target and a +26% Gain

Key Takeaways

  • The central $39 target is the arithmetic mean of eight verified analyst price targets, rounded from a calculated average of $38.50.
  • Shares recently traded around $31, so reaching $39 requires a gain of roughly 26% — a substantial move, not a trivial one.
  • The target range is unusually wide, from $25 (Barclays) to $47 (Jefferies), reflecting sharp disagreement over insurance-volume headwinds.
  • Bullish analysts emphasize Copart's dominant salvage-auction position and its completed acquisition of ACV Auctions (ACVA); the bearish case centers on declining U.S. insurance units and possible market-share loss.
  • The biggest risks are persistent auto-insurance pricing pressure, potential share erosion to competitor RB Global (RBA), and valuation compression.
  • For more detail, explore Major News, Today's Price Move, the Forecast page, and Earnings coverage for CPRT.
  • Readers can also explore Trending AI Robots to see AI-driven trading strategies applied across the market.

Analyst Price Targets and Consensus View

The $39 central target reflects eight individual analyst price targets verified across recent research. The calculated mean of those targets is $38.50, rounded to $39 for readability. The range spans $25 (Barclays, Sell) to $47 (Jefferies, Buy), a roughly 88% gap between the most and least optimistic views that underscores how divided the Street has become. On the bullish side, Copart draws Buy or Outperform ratings from Baird ($38), J.P. Morgan ($40), Barrington ($40), Freedom Capital Markets ($39), BNP Paribas ($43), and Jefferies ($47). HSBC moved to the sidelines with a Hold and a $36 target, while Barclays' $25 Sell rating stands out as a notable dissenter. Recent action has been mixed: BNP Paribas raised its target in late September, but Baird lowered its target from $42 to $38 in October, and Barclays reiterated its bearish stance into November. Analysts broadly agree on the fundamentals — dominant market position, high margins, and a debt-light balance sheet — but disagree sharply on whether the decline in U.S. insurance volumes is cyclical or structural, which is why the spread between targets is so wide. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position and Path Toward the Target

With shares near $31, reaching $39 implies upside of about 26%. By conventional standards, that qualifies as a substantial move — achievable only with a meaningful improvement in the volume narrative, not just steady-state performance. Copart's market capitalization is roughly $28.6 billion, with trailing earnings per share (EPS) around $1.55 and a price-to-earnings (P/E) ratio near 20. The path toward $39 would likely require stabilization and eventual recovery in U.S. insurance assignment volumes. Copart has reported three consecutive quarters of declining U.S. insurance units excluding catastrophe events, driven by elevated auto-insurance premiums that prompted policyholders to reduce coverage and report fewer claims. Offsetting this, higher average selling prices and international expansion have kept revenue roughly flat. A sustained rebound in units — or faster-than-expected contribution from the newly acquired ACV platform — would be the clearest route toward the target.

What Could Support a Move Toward the Target

  • Durable competitive moat. Copart owns more than 90% of its roughly 21,000 acres of yards, and its global buyer base is difficult to replicate.
  • ACV Auctions acquisition. The completed ~$1.9 billion deal extends Copart into dealer trade-ins and wholesale remarketing, broadening its addressable market beyond salvage.
  • Insurance-cycle normalization. Auto-insurance price growth has slowed toward flat or negative, and several carriers are guiding to premium cuts, which could eventually revive claim volumes.
  • Margin and balance-sheet strength. Net margins near 30% and minimal debt give Copart flexibility to invest or repurchase shares.

What Could Prevent the Target From Being Reached

  • Volume share loss. Sell-side notes have cited Progressive shifting a portion of salvage volume toward IAA, which could prove structural rather than temporary.
  • Slowing growth. Analysts project only low-single-digit revenue growth in the near term, far below Copart's historical double-digit pace.
  • Earnings misses. Fourth-quarter fiscal 2026 EPS of $0.35 came in below consensus, adding to sentiment pressure.
  • Valuation compression. If growth expectations reset lower, the stock's premium multiple could remain under pressure even if the business stabilizes.

Technical Levels and Market Structure

Copart's 52-week range spans roughly $25.72 to $41.79, placing the stock near the lower-middle of that band after a rebound from the November low. The 50-day moving average sits near $29.45 while the 200-day average is around $32.22, meaning the stock remains below its longer-term trend line — a sign that the recovery is not yet confirmed. The $40 area, just above the target, aligns with prior resistance and a psychological round-number level, while $25.72 marks the key support that has so far held. From what I see, the technical setup suggests the stock needs a clear break above the 200-day average to build momentum.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a research horizon of roughly 12 months, though individual firms vary. The next major catalyst is Copart's first-quarter fiscal 2027 results, scheduled for release on December 1, 2026. Investors should watch U.S. insurance unit trends, average selling prices, commentary on the ACV integration, and any analyst target revisions that follow. Broader signals — auto-insurance pricing, total-loss frequency, and new-car affordability — will also shape whether the volume headwind fades. I’m watching this closely ahead of the earnings release.

Using AI Daily Buy/Sell Signals for Additional Insight

In my view, layering an automated perspective on top of the fundamentals can help clarify the picture. Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and identify changing trends more efficiently than manual screening allows. For those following names like CPRT, it offers a data-driven complement to fundamental research. One thing that stands out is how these signals can flag shifts in momentum that align with the volume trends discussed earlier.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CPRT

CPRT sees MACD Histogram just turned negative

CPRT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 18, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 40 instances where the indicator turned negative. In 27 of the 40 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CPRT moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In 19 of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 59 cases where CPRT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 64%.

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CPRT as a result. In 49 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPRT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

CPRT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

CPRT moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CPRT crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 63%.

Following a +8.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where CPRT advanced for three days, in 179 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.

The Aroon Indicator entered an Uptrend today. In 112 of 224 cases where CPRT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 50%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 53 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. CPRT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.251) is normal, around the industry mean (5.887). P/E Ratio (20.481) is within average values for comparable stocks, (33.618). Projected Growth (PEG Ratio) (2.678) is also within normal values, averaging (1.946). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (6.321) is also within normal values, averaging (9.907).

The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CPRT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Industry description

The industry produces equipment regularly used in offices by businesses and other organizations, and could range from items like Blank sheet paper, calendars, Label and adhesive paper, paper clips, janitorial supplies, to larger /higher cost products like computers, printers, photocopiers, office furniture and so on. Many businesses in the office supply industry have been expanding into related markets like business cards, plus printing and binding of high quality, high volume business and engineering documents. Some companies in this industry also offer shipping services, including packaging and bulk mailing. Herman Miller, Inc., Steelcase Inc. and HNI Corporation.

Market Cap

The average market capitalization across the Office Equipment/Supplies Industry is 8.05B. The market cap for tickers in the group ranges from 47.27K to 88.84B. CTAS holds the highest valuation in this group at 88.84B. The lowest valued company is KUBR at 47.27K.

High and low price notable news

The average weekly price growth across all stocks in the Office Equipment/Supplies Industry was 46%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -10%. PMEC experienced the highest price growth at 48%, while SMX experienced the biggest fall at -75%.

Volume

The average weekly volume growth across all stocks in the Office Equipment/Supplies Industry was 30%. For the same stocks of the Industry, the average monthly volume growth was 141% and the average quarterly volume growth was 104%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 58
Price Growth Rating: 58
SMR Rating: 73
Profit Risk Rating: 83
Seasonality Score: 10 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of online auctions and vehicle remarketing services

Industry OfficeEquipmentSupplies

Industry
Miscellaneous Commercial Services
Address
14185 Dallas Parkway
Phone
+1 972 391-5000
Employees
11600
Web
https://www.copart.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.